Safety and Efficacy Evaluation of CD19-UCART

Clinical trial NCT03229876 · SUSPENDED

Trial details

NCT number: NCT03229876
Sponsor: Bioray Laboratories
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)

Start date: 2019-06-01
Primary completion: 2023-12-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.